Similar articles for PMID: 18771053

Year	Number of Results
1998	1
1999	1
2000	8
2001	4
2002	7
2003	2
2004	3
2005	3
2006	3
2007	6
2008	10
2009	5
2010	9
2011	4
2012	3
2013	11
2014	3
2015	3
2016	10
2017	8
2018	4
2019	6
2020	3
2021	1
2022	5
2023	1
2024	0

1

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.

Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, Ngeth C, Ferradini L, Delfraissy JF, Laureillard D. Spire B, et al. Antivir Ther. 2008;13(5):697-703. Antivir Ther. 2008. PMID: 18771053 Free article.

2

Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.

Shet A, Kumarasamy N, Poongulali S, Shastri S, Kumar DS, Rewari BB, Arumugam K, Antony J, De Costa A, D'Souza G. Shet A, et al. Curr HIV Res. 2016;14(1):71-9. doi: 10.2174/1570162x13666150825123750. Curr HIV Res. 2016. PMID: 26303008

3

Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.

Zoufaly A, Fillekes Q, Hammerl R, Nassimi N, Jochum J, Drexler JF, Awasom CN, Sunjoh F, Burchard GD, Burger DM, van Lunzen J, Feldt T. Zoufaly A, et al. Antivir Ther. 2013;18(5):681-90. doi: 10.3851/IMP2562. Epub 2013 Mar 18. Antivir Ther. 2013. PMID: 23502762

4

Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon.

Meresse M, Carrieri MP, Laurent C, Kouanfack C, Protopopescu C, Blanche J, Cohen J, Laborde-Balen G, Aghokeng AF, Spire B, Moatti JP, Delaporte E, Boyer S; Stratall ANRS 12110/ESTHER Study Group. Meresse M, et al. Antivir Ther. 2013;18(1):29-37. doi: 10.3851/IMP2535. Epub 2013 Jan 29. Antivir Ther. 2013. PMID: 23358393 Clinical Trial.

5

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial.

BREATHER (PENTA 16) Trial Group. BREATHER (PENTA 16) Trial Group. Lancet HIV. 2016 Sep;3(9):e421-e430. doi: 10.1016/S2352-3018(16)30054-6. Epub 2016 Jun 20. Lancet HIV. 2016. PMID: 27562743 Free PMC article. Clinical Trial.

6

Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.

Chung MH, McGrath CJ, Beck IA, Levine M, Milne RS, So I, Andersen N, Dross S, Coombs RW, Chohan B, Yatich N, Kiptinness C, Sakr SR, Kiarie JN, Frenkel LM. Chung MH, et al. Lancet HIV. 2020 Feb;7(2):e104-e112. doi: 10.1016/S2352-3018(19)30337-6. Epub 2019 Dec 7. Lancet HIV. 2020. PMID: 31818716 Free PMC article. Clinical Trial.

7

Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study.

Sudjaritruk T, Teeraananchai S, Kariminia A, Lapphra K, Kumarasamy N, Fong MS, Hansudewechakul R, Bunupuradah T, Ly PS, Nallusamy RA, Sohn AH, Sirisanthana V; TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific. Sudjaritruk T, et al. J Int AIDS Soc. 2020 Jul;23(7):e25550. doi: 10.1002/jia2.25550. J Int AIDS Soc. 2020. PMID: 32628816 Free PMC article.

8

High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia.

Isaakidis P, Raguenaud ME, Te V, Tray CS, Akao K, Kumar V, Ngin S, Nerrienet E, Zachariah R. Isaakidis P, et al. J Int AIDS Soc. 2010 Mar 21;13:11. doi: 10.1186/1758-2652-13-11. J Int AIDS Soc. 2010. PMID: 20302672 Free PMC article.

9

Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study.

Chendi BH, Okomo Assoumou MC, Jacobs GB, Yekwa EL, Lyonga E, Mesembe M, Eyoh A, Ikomey GM. Chendi BH, et al. BMC Infect Dis. 2019 Feb 26;19(1):194. doi: 10.1186/s12879-019-3824-7. BMC Infect Dis. 2019. PMID: 30808298 Free PMC article.

10

A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.

Arranz Caso JA, López JC, Santos I, Estrada V, Castilla V, Sanz J, Sanz J, Molina JP, Fernández Guerrero M, Górgolas M. Arranz Caso JA, et al. HIV Med. 2005 Sep;6(5):353-9. doi: 10.1111/j.1468-1293.2005.00320.x. HIV Med. 2005. PMID: 16156884 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

115 results

Results by year